Spasenija Savic Prince Selected Research

Spasenija Savic Prince Research Topics

8	Neoplasms (Cancer) 05/2022 - 01/2019
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Hypoxia (Hypoxemia) 11/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Carcinoma (Carcinomatosis) 09/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Tertiary Lymphoid Structures 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Pathologic Constriction (Stenosis) 01/2018
1	Exercise-Induced Asthma (Asthma, Exercise Induced) 01/2018
1	Squamous Intraepithelial Lesions 08/2013
1	Atypical Squamous Cells of the Cervix 08/2013

5	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2019
2	ParaffinIBA 05/2022 - 01/2019
2	Formaldehyde (Formol)FDA Link 05/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 04/2019
2	CytokinesIBA 01/2020 - 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Docetaxel (Taxotere)FDA Link 10/2021
1	durvalumabIBA 10/2021
1	Keratins (Keratin)IBA 04/2021
1	dabrafenibIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 01/2020
1	LigandsIBA 01/2020
1	Interleukin-13IBA 01/2020
1	pembrolizumabIBA 04/2019
1	B7-H1 AntigenIBA 01/2019
1	Thyroid Nuclear Factor 1IBA 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	telomerase RNA (bTR)IBA 08/2013